2025 annual financial data
Jazz Pharmaceuticals 2025 Operating margin
Jazz Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 5.26%.
Operating income was 224,421,000 USD and net income was -356,148,000 USD.
Operating cash flow was 1,355,773,000 USD.
Get free Jazz Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,267,586,000 USD
- Operating income
- 224,421,000 USD
- Net income
- -356,148,000 USD
- Operating cash flow
- 1,355,773,000 USD